INDGN578.00

Indegene Ltd.

· Pharma & Health
₹ CrorePeersSYNGENELTTSGRANULESJUBLPHARMAKIMSERISEMCUREONESOURCEMcap ₹13,901 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation76.180.2126.5
+ Finance Costs47.119.415.9
+ Interest Income-29.6-50.1-17.1
+ Dividend Income0.00.0-19.2
+ Share-based Payments21.317.425.6
+ Unrealised FX (Gain) / Loss-6.41.75.4
+ Other Non-cash Items-13.80.0-9.9
+ Other Reconciling Items-16.5-30.10.0
Changes in Working Capital
+ Trade Receivables — Current31.2-82.03.5
+ Other Current Assets-30.134.3-23.1
+ Other Current Liabilities74.261.1143.7
+ Provisions — Current20.510.722.1
Cash from Operating Activities
Profit Before Tax (per I/S)458.6539.3525.0525.6
+ Total Adjustments (incl. Working Capital)174.062.6273.4
Cash from Operations (pre-tax)632.6601.9798.4
+ Income Taxes Paid124.9160.0147.6
Cash from Operating Activities507.7441.9650.8
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)10.730.044.3
+ Purchase of Investments (Equity / Debt)172.1111.30.0
+ Loans & Advances Made13.50.00.0
+ Interest Received — Investing26.148.612.6
+ Other Inflows / (Outflows) — Investing-157.0-590.0-480.7
Cash from Investing Activities-327.2-682.7-512.4
Cash from Financing Activities
+ Proceeds from Issue of Shares0.0732.75.3
+ Repayment of Borrowings6.7403.10.0
+ Payment of Lease Liabilities27.90.039.9
+ Interest Paid31.610.30.0
+ Dividends Paid0.00.048.0
+ Income Taxes (Paid) / Refund — Financing0.031.80.0
Cash from Financing Activities-66.2287.5-82.6
Net Changes in Cash (pre-FX)114.346.755.8
+ Effect of FX Rate Changes on Cash0.75.74.0
Net Changes in Cash115.052.459.8
Closing Cash188.6241.0300.8
Reference Items
EBITDA505.4534.3619.0637.9
EBITDA Margin %19.5218.8217.6316.73
Free Cash Flow (CFO − Capex)497.0411.9606.5606.5
Free Cash Flow to Equity-1.5606.5
Free Cash Flow per Basic Share20.6717.1325.2225.22
Price to Free Cash Flow22.92
Cash Flow to Net Income1.511.091.62
Cash Paid for Taxes124.9160.0147.6
Cash Paid for Interest31.610.30.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.